Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19

Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19

No abstract present.

Bibliographic Details
Main Authors: Liudmila Buryachkovskaya, Nikita Lomakin, Arthur Melkumyants, Julia Docenko, Victor Serebruany
Format: Article
Language:English
Published: IMR (Innovative Medical Research) Press Limited 2021-09-01
Series:Reviews in Cardiovascular Medicine
Online Access:https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453053480-331266834.pdf
id doaj-7ad08724d8134bd28a71e9efe6e25fb0
record_format Article
spelling doaj-7ad08724d8134bd28a71e9efe6e25fb02021-09-26T07:42:31ZengIMR (Innovative Medical Research) Press LimitedReviews in Cardiovascular Medicine2153-81742021-09-0122354955110.31083/j.rcm22030651632453053480-331266834Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19Liudmila Buryachkovskaya0Nikita Lomakin1Arthur Melkumyants2Julia Docenko3Victor Serebruany4National Cardiology Research Center, 121552 Moscow, RussiaCardiology Division, Central Clinical Hospital of Presidential Administration, 121359 Moscow, RussiaNational Cardiology Research Center, 121552 Moscow, RussiaNational Cardiology Research Center, 121552 Moscow, RussiaNeurology, Johns Hopkins University, Baltimore, MD 21794, USANo abstract present.https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453053480-331266834.pdf
collection DOAJ
language English
format Article
sources DOAJ
author Liudmila Buryachkovskaya
Nikita Lomakin
Arthur Melkumyants
Julia Docenko
Victor Serebruany
spellingShingle Liudmila Buryachkovskaya
Nikita Lomakin
Arthur Melkumyants
Julia Docenko
Victor Serebruany
Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19
Reviews in Cardiovascular Medicine
author_facet Liudmila Buryachkovskaya
Nikita Lomakin
Arthur Melkumyants
Julia Docenko
Victor Serebruany
author_sort Liudmila Buryachkovskaya
title Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19
title_short Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19
title_full Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19
title_fullStr Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19
title_full_unstemmed Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19
title_sort impact of olokizumab on platelets, leukocytes and erythrocytes during mild covid-19
publisher IMR (Innovative Medical Research) Press Limited
series Reviews in Cardiovascular Medicine
issn 2153-8174
publishDate 2021-09-01
description No abstract present.
url https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453053480-331266834.pdf
work_keys_str_mv AT liudmilaburyachkovskaya impactofolokizumabonplateletsleukocytesanderythrocytesduringmildcovid19
AT nikitalomakin impactofolokizumabonplateletsleukocytesanderythrocytesduringmildcovid19
AT arthurmelkumyants impactofolokizumabonplateletsleukocytesanderythrocytesduringmildcovid19
AT juliadocenko impactofolokizumabonplateletsleukocytesanderythrocytesduringmildcovid19
AT victorserebruany impactofolokizumabonplateletsleukocytesanderythrocytesduringmildcovid19
_version_ 1716868396809715712

Similar Items